NEW YORK – DNAnexus said on Wednesday that it has signed a partnership with Oracle to integrate the companies’ products for precision health data analysis.
Financial terms of the deal were not disclosed.
As part of the collaboration, the firms will make the DNAnexus data management and analysis platform available to Oracle Cloud Infrastructure (OCI), Oracle Health, and Oracle Database customers. Additionally, customers can use OCI integration services for their healthcare applications.
The firms also plan to leverage Oracle’s expertise in AI pipelines and its industry partnerships to speed up genomic analyses and improve AI models. DNAnexus said it is already using the OCI AI infrastructure to run genomic reports.
"Oracle’s focus on the simultaneous rapid global deployment of its cloud and electronic health records aligns very well with our industry-leading platform, which allows scientific innovators and healthcare professionals to manage, analyze, and collaborate on multiomic, clinical, and real-world data," said DNAnexus CEO Thomas Laur in a statement.
"Oracle’s vast ecosystem of partners and global footprint of 69 cloud regions is helping organizations accelerate innovations in healthcare and life sciences," added Dan Spellman, global AI cloud director at Oracle. "Paired with DNAnexus’ expertise in genomic data management and analysis, we’re ultimately unlocking new insights and driving advancements in personalized medicine and healthcare."
DNAnexus, which recently underwent a restructuring, has struck a number of similar data analysis collaborations in the past, including with Curio Bioscience and TMA Precision Health.